{"id":"placebo-of-simvastatin","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL1201391","moleculeType":"Small molecule","molecularWeight":"436.59"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"A placebo is an inert substance administered in blinded clinical trials to serve as a control comparator. In this case, it is used in Phase 3 trials of simvastatin (an HMG-CoA reductase inhibitor) to evaluate the efficacy and safety of the active drug by comparing outcomes between placebo-treated and simvastatin-treated groups.","oneSentence":"This is a placebo control formulation used in clinical trials to compare against the active simvastatin drug and has no therapeutic mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:38.569Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in Phase 3 clinical trials of simvastatin (active comparator for hyperlipidemia/cardiovascular risk reduction)"}]},"trialDetails":[{"nctId":"NCT02968810","phase":"PHASE2","title":"Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2017-06-21","conditions":"Cirrhosis, Hepatocellular Carcinoma","enrollment":52},{"nctId":"NCT06566794","phase":"NA","title":"KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2024-08-22","conditions":"Drug Interaction","enrollment":12},{"nctId":"NCT00858637","phase":"PHASE3","title":"Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2009-03","conditions":"Chronic Kidney Disease","enrollment":260},{"nctId":"NCT03654053","phase":"PHASE3","title":"Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2020-10-02","conditions":"Cirrhosis","enrollment":142},{"nctId":"NCT04133792","phase":"PHASE3","title":"Effect of Simvastatin on the Prognosis of Primary Primary Sclerosing Cholangitis (PSC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Annika Bergquist","startDate":"2020-10-01","conditions":"Primary Sclerosing Cholangitis","enrollment":571},{"nctId":"NCT03400826","phase":"PHASE2","title":"Effects of Simvastatin on Uterine Leiomyoma Size","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2018-08-20","conditions":"Fibroid Uterus, Fibroid Tumor, Leiomyoma","enrollment":60},{"nctId":"NCT03896217","phase":"PHASE2","title":"Simvastatin in Secondary Progressive Multiple Sclerosis","status":"COMPLETED","sponsor":"University College, London","startDate":"2019-05-16","conditions":"Secondary Progressive Multiple Sclerosis","enrollment":40},{"nctId":"NCT07031778","phase":"EARLY_PHASE1","title":"Topic Simvastatin for Bone Regeneration","status":"RECRUITING","sponsor":"Universidad de Granada","startDate":"2025-01-07","conditions":"Dimensional Changes, Bone Density","enrollment":90},{"nctId":"NCT00678743","phase":"PHASE4","title":"An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin","status":"COMPLETED","sponsor":"Provident Clinical Research","startDate":"2007-08","conditions":"Dyslipidemias","enrollment":17},{"nctId":"NCT04021498","phase":"PHASE3","title":"Simvastatin in the Prevention of Recurrent Pancreatitis","status":"TERMINATED","sponsor":"Enrique de-Madaria","startDate":"2017-09-29","conditions":"Pancreatitis Relapsing","enrollment":83},{"nctId":"NCT01602029","phase":"PHASE2","title":"Randomized Double Blind Placebo Control Study in Patients with Schizophrenia","status":"COMPLETED","sponsor":"Pakistan Institute of Living and Learning","startDate":"2010-08","conditions":"Schizophrenia, Schizoaffective Disorder, Psychosis Not Otherwise Specified","enrollment":303},{"nctId":"NCT04971577","phase":"PHASE2, PHASE3","title":"Efficacy of Simvastatin in Alcoholic Liver Fibrosis","status":"RECRUITING","sponsor":"Anna Cruceta","startDate":"2022-02-22","conditions":"Liver Fibrosis, Alcohol Abuse","enrollment":90},{"nctId":"NCT05550415","phase":"PHASE2","title":"The Role of Simvastatin in the Epithelial-Mesenchymal Transition Process of Breast Cancer","status":"RECRUITING","sponsor":"Indonesia University","startDate":"2022-08-19","conditions":"Triple Negative Breast Cancer, Chemotherapy Effect, Simvastatin Adverse Reaction","enrollment":26},{"nctId":"NCT03387670","phase":"PHASE3","title":"Multiple Sclerosis-Simvastatin Trial 2","status":"COMPLETED","sponsor":"University College, London","startDate":"2018-03-28","conditions":"Secondary Progressive Multiple Sclerosis (SPMS)","enrollment":964},{"nctId":"NCT00092651","phase":"PHASE3","title":"A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-09","conditions":"Hypercholesterolemia","enrollment":1398},{"nctId":"NCT00650819","phase":"PHASE3","title":"Comparison of Ezetimibe Plus Simvastatin Versus Ezetimibe or Simvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03757)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-06-01","conditions":"Hypercholesterolemia","enrollment":240},{"nctId":"NCT00552097","phase":"PHASE3","title":"Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-06-01","conditions":"Atherosclerosis, Hypercholesterolemia, Hyperlipoproteinemia Type II","enrollment":720},{"nctId":"NCT00092664","phase":"PHASE3","title":"An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-01","conditions":"Hypercholesterolemia","enrollment":1104},{"nctId":"NCT00653835","phase":"PHASE4","title":"Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-09-01","conditions":"Hypercholesterolaemia, Atherosclerosis","enrollment":153},{"nctId":"NCT00110435","phase":"PHASE3","title":"A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-05","conditions":"Type 2 Diabetes Mellitus, Hypercholesterolemia","enrollment":1229},{"nctId":"NCT00652301","phase":"PHASE3","title":"A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-07","conditions":"Cholesterol","enrollment":40},{"nctId":"NCT00651274","phase":"PHASE4","title":"Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-04-01","conditions":"Atherosclerosis, Hypercholesterolemia, Coronary Heart Disease","enrollment":144},{"nctId":"NCT00389896","phase":"PHASE3","title":"A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-07-26","conditions":"HDL Cholesterol","enrollment":150},{"nctId":"NCT00092612","phase":"PHASE3","title":"Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-05","conditions":"Hypercholesterolemia, Coronary Disease","enrollment":372},{"nctId":"NCT00092599","phase":"PHASE3","title":"Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-02","conditions":"Hypercholesterolemia, Coronary Disease","enrollment":410},{"nctId":"NCT00651391","phase":"PHASE3","title":"Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2003-10-01","conditions":"Hypercholesterolemia, Atherosclerosis","enrollment":28},{"nctId":"NCT04973800","phase":"NA","title":"Simvastatin and Emotional Processing (OxSTEP)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2021-07-05","conditions":"Depression, Inflammation","enrollment":101},{"nctId":"NCT00202878","phase":"PHASE3","title":"IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-10-17","conditions":"Hypercholesterolemia, Myocardial Infarction","enrollment":18144},{"nctId":"NCT00739050","phase":"PHASE4","title":"Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2007-09-19","conditions":"Systemic Lupus Erythematosus","enrollment":4},{"nctId":"NCT00423579","phase":"PHASE4","title":"The Effects of Ezetimibe/Simvastatin 10/20 mg Versus Simvastatin 40 mg in High Cholesterol and Coronary Heart Disease Study (P04039AM2)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-07-01","conditions":"Hypercholesterolemia, Coronary Disease","enrollment":120},{"nctId":"NCT00535405","phase":"PHASE3","title":"A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-11","conditions":"Hypercholesterolemia","enrollment":1289},{"nctId":"NCT00409773","phase":"PHASE3","title":"Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-01","conditions":"Hypercholesterolemia, Metabolic Syndrome","enrollment":1143},{"nctId":"NCT00092677","phase":"PHASE3","title":"An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-01","conditions":"Aortic Stenosis","enrollment":1873},{"nctId":"NCT00479713","phase":"PHASE3","title":"A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-02-01","conditions":"Hypercholesterolemia","enrollment":618},{"nctId":"NCT00271817","phase":"PHASE3","title":"To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-12","conditions":"Hypercholesterolemia","enrollment":1220},{"nctId":"NCT03882905","phase":"PHASE3","title":"A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-01-31","conditions":"Primary Hypercholesterolemia","enrollment":769},{"nctId":"NCT03884452","phase":"PHASE3","title":"Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-05-03","conditions":"Familial Hypercholesterolemia","enrollment":50},{"nctId":"NCT01420328","phase":"NA","title":"To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects","status":"COMPLETED","sponsor":"University at Buffalo","startDate":"2011-05-01","conditions":"Inflammation","enrollment":20},{"nctId":"NCT00587717","phase":"NA","title":"The Acute Effect of Statins on Inflammatory Markers of Athersclerotic Tissue","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2002-09","conditions":"Carotid Artery Disease","enrollment":35},{"nctId":"NCT02133521","phase":"PHASE2, PHASE3","title":"DLBS1033 for Acute Ischemic Stroke Patients","status":"TERMINATED","sponsor":"Dexa Medica Group","startDate":"2014-11-11","conditions":"Acute Ischemic Stroke, Partial Anterior Circulation Infarct, Lacunar Anterior Circulation Infarct","enrollment":80},{"nctId":"NCT00988364","phase":"PHASE4","title":"Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome.","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2007-03","conditions":"Metabolic Syndrome","enrollment":30},{"nctId":"NCT03780673","phase":"PHASE2, PHASE3","title":"Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent ACLF Development","status":"COMPLETED","sponsor":"Judit Pich","startDate":"2019-01-03","conditions":"Liver Cirrhoses","enrollment":254},{"nctId":"NCT02713945","phase":"PHASE3","title":"Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2017-01-25","conditions":"Noonan Syndrome","enrollment":53},{"nctId":"NCT03510884","phase":"PHASE3","title":"An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-05-31","conditions":"Hypercholesterolaemia","enrollment":153},{"nctId":"NCT00655993","phase":"PHASE1","title":"Effect of Statin Therapy on C-reactive Protein Levels in Patients With Chronic Obstructive Lung Disease (COPD)","status":"COMPLETED","sponsor":"VA Loma Linda Health Care System","startDate":"2008-04","conditions":"COPD, Inflammation","enrollment":30},{"nctId":"NCT05511766","phase":"PHASE2, PHASE3","title":"Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2022-11-15","conditions":"Cirrhosis, Hepatic Encephalopathy, Ascites","enrollment":150},{"nctId":"NCT04507373","phase":"PHASE4","title":"7T Magnetic Resonance Spectroscopy and Skeletal Muscle Biopsy Findings in Statin Associated Adverse Muscle Events","status":"TERMINATED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2018-08-17","conditions":"Muscle Cramp, Ache, Weakness, Muscle","enrollment":3},{"nctId":"NCT05580250","phase":"PHASE1","title":"A Study of LY3526318 in Healthy Male Japanese Participants","status":"WITHDRAWN","sponsor":"Eli Lilly and Company","startDate":"2022-11-22","conditions":"Healthy","enrollment":""},{"nctId":"NCT02743364","phase":"PHASE2","title":"Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2016-09-19","conditions":"Acute Pancreatitis","enrollment":8},{"nctId":"NCT05613400","phase":"PHASE4","title":"Statin and Bone Health","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2022-04-13","conditions":"Diabetes Mellitus, Type 2","enrollment":240},{"nctId":"NCT01763866","phase":"PHASE3","title":"LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2","status":"COMPLETED","sponsor":"Amgen","startDate":"2013-01-15","conditions":"Hyperlipidemia","enrollment":2067},{"nctId":"NCT02850081","phase":"PHASE3","title":"Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes","status":"COMPLETED","sponsor":"Columbia University","startDate":"2017-06-01","conditions":"Carotid Artery Stenosis, Strokes","enrollment":31},{"nctId":"NCT04652089","phase":"PHASE1, PHASE2","title":"7-day Simvastatin and Emotional Processing","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2020-12-03","conditions":"Depression, Inflammation","enrollment":53},{"nctId":"NCT05551871","phase":"NA","title":"Effects of Usage of Simvastatin in Mild to Moderate Traumatic Brain Injury (TBI) Patients. Could it Make a Difference?","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2022-10-01","conditions":"Traumatic Brain Injury","enrollment":60},{"nctId":"NCT02871687","phase":"PHASE1","title":"Effect of Statin Use on Aldosterone Secretion","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2016-04","conditions":"Healthy Subjects","enrollment":103},{"nctId":"NCT01715714","phase":"PHASE4","title":"Statin Recapture Therapy Before Coronary Artery Bypass Grafting","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2012-11-07","conditions":"Coronary Artery Disease","enrollment":2630},{"nctId":"NCT05369091","phase":"PHASE4","title":"Salivary Bmp-2 Levels & Radiographic Measurement Of Bone Density at Extracted Tooth","status":"COMPLETED","sponsor":"Postgraduate Medical Institute, Lahore","startDate":"2020-12-16","conditions":"Bone Injury","enrollment":24},{"nctId":"NCT01047501","phase":"PHASE3","title":"Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)","status":"COMPLETED","sponsor":"Amarin Pharma Inc.","startDate":"2009-12","conditions":"Hypertriglyceridemia","enrollment":702},{"nctId":"NCT01047683","phase":"PHASE3","title":"Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL","status":"COMPLETED","sponsor":"Amarin Pharma Inc.","startDate":"2009-12","conditions":"Hypertriglyceridemia","enrollment":229},{"nctId":"NCT01492361","phase":"PHASE3","title":"A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin","status":"COMPLETED","sponsor":"Amarin Pharma Inc.","startDate":"2011-11","conditions":"Cardiovascular Diseases","enrollment":8179},{"nctId":"NCT02476006","phase":"PHASE3","title":"Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-06-23","conditions":"Hypercholesterolemia","enrollment":998},{"nctId":"NCT05187715","phase":"NA","title":"To Study the Safety and Efficacy of Simvastatin in Patients With Hepatopulmonary Syndrome in Cirrhosis.","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2022-02-26","conditions":"Liver Cirrhosis","enrollment":45},{"nctId":"NCT00652444","phase":"PHASE4","title":"Effect Of Ezetimibe Coadministration With Simvastatin In A Middle Eastern Population: A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial (0653-151)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-09","conditions":"Hypercholesterolemia","enrollment":120},{"nctId":"NCT00651014","phase":"PHASE4","title":"Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2004-01","conditions":"Hypercholesterolemia, Atherosclerosis","enrollment":82},{"nctId":"NCT00413972","phase":"PHASE3","title":"Effects of Vytorin Versus Placebo in Subjects With Primary Hypercholesterolemia (Study P04420)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04","conditions":"Hypercholesterolemia","enrollment":392},{"nctId":"NCT00423488","phase":"PHASE3","title":"Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-07-12","conditions":"Hypercholesterolemia, Diabetes Mellitus, Type 2, Coronary Disease","enrollment":93},{"nctId":"NCT01077830","phase":"","title":"An Observational Follow-Up Study of the Incidence of Cancer and Mortality in Patients From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Trial (MK-0653A-043-10)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-03","conditions":"Cancer","enrollment":1392},{"nctId":"NCT00129402","phase":"PHASE3","title":"Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-08","conditions":"Hypercholesterolemia","enrollment":248},{"nctId":"NCT01952288","phase":"PHASE4","title":"Simvastatin for mTBI","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2013-09-16","conditions":"TBI-Traumatic Brain Injury","enrollment":5},{"nctId":"NCT02946424","phase":"PHASE2","title":"Simvastatin to Prevent SCI-Induced Bone Loss","status":"UNKNOWN","sponsor":"Craig Hospital","startDate":"2017-07-01","conditions":"Spinal Cord Injuries, Osteoporosis","enrollment":76},{"nctId":"NCT02787590","phase":"PHASE2","title":"Simvastatin as a Neuroprotective Treatment for Moderate Parkinson's Disease","status":"COMPLETED","sponsor":"University Hospital Plymouth NHS Trust","startDate":"2016-03-08","conditions":"Parkinson Disease","enrollment":235},{"nctId":"NCT02490527","phase":"NA","title":"Effects of Epicatechin on Statins for Mitochondrial Dysfunction and Impaired Exercise Capacity","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2015-06","conditions":"Statin Intolerance","enrollment":19},{"nctId":"NCT01646437","phase":"PHASE3","title":"The International Polycap Study 3 (TIPS-3)","status":"COMPLETED","sponsor":"Population Health Research Institute","startDate":"2012-06","conditions":"Cardiovascular Disease, Fractures, Cancers","enrollment":7793},{"nctId":"NCT03435744","phase":"PHASE3","title":"Simvastatin as an Augmentation Treatment for Treatment Resistant Depression: Randomized Controlled Trial.","status":"COMPLETED","sponsor":"Pakistan Institute of Living and Learning","startDate":"2019-01-01","conditions":"Treatment Resistant Depression, Major Depressive Disorder","enrollment":150},{"nctId":"NCT02714569","phase":"PHASE1","title":"A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2016-03","conditions":"Dyslipidemias","enrollment":60},{"nctId":"NCT00720577","phase":"EARLY_PHASE1","title":"Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.","status":"COMPLETED","sponsor":"Medtronic Endovascular","startDate":"2005-12","conditions":"Peripheral Arterial Disease","enrollment":164},{"nctId":"NCT04885153","phase":"NA","title":"Effects of Oral Fenofibrate on Retinal Thickness and Macular Volume","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2016-11-01","conditions":"Diabetic Retinopathy, Dyslipidemias, Diabetes Mellitus","enrollment":36},{"nctId":"NCT04836078","phase":"EARLY_PHASE1","title":"Role of Simvastatin Microsponges in Treatment of Periodontitis","status":"COMPLETED","sponsor":"Assiut University","startDate":"2020-02-10","conditions":"Periodontitis","enrollment":24},{"nctId":"NCT04803500","phase":"PHASE2","title":"Simvastatin Around Immediate Implant","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2015-04-02","conditions":"Immediate Implant Placement, Bone Regeneration, Alveolar Bone Resorption","enrollment":10},{"nctId":"NCT01035320","phase":"PHASE4","title":"Platelet Function in Diabetic Patients With and Without Renal Impairment, and the Effects of Lipid Lowering Treatment","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2006-01","conditions":"Diabetes Mellitus, Impaired Renal Function","enrollment":39},{"nctId":"NCT02796378","phase":"PHASE4","title":"Living With Statins - Interventional Exercise Study","status":"UNKNOWN","sponsor":"University of Copenhagen","startDate":"2016-06","conditions":"Cardiovascular Disease, Diabetes Mellitus","enrollment":30},{"nctId":"NCT01487460","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2011-11","conditions":"Dyslipidemia, Healthy Volunteers","enrollment":137},{"nctId":"NCT01859455","phase":"PHASE1","title":"Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2011-07","conditions":"Hypercholesterolemia, LDL Cholesterol","enrollment":25},{"nctId":"NCT03929744","phase":"PHASE1","title":"A Study of LY3502970 in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2019-06-12","conditions":"Healthy","enrollment":133},{"nctId":"NCT00477204","phase":"PHASE2","title":"Clinical Trial of Zocor (Simvastatin) and Vytorin (Ezetimibe/Simvastatin) in Adolescents With Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2007-05","conditions":"Type 1 Diabetes Mellitus, Dyslipidemia","enrollment":9},{"nctId":"NCT01999309","phase":"PHASE3","title":"Simvastatin Addition for Patients With Recent-onset Schizophrenia","status":"COMPLETED","sponsor":"Iris Sommer","startDate":"2013-10","conditions":"Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder","enrollment":121},{"nctId":"NCT03134157","phase":"PHASE3","title":"The Effect of Simvastatin on Uterine Leiomyoma Development and Growth in Infertile Women","status":"UNKNOWN","sponsor":"Royan Institute","startDate":"2016-08","conditions":"Infertility","enrollment":60},{"nctId":"NCT03247400","phase":"PHASE1, PHASE2","title":"The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo","status":"COMPLETED","sponsor":"Nicolaus Copernicus University","startDate":"2016-12-01","conditions":"Non-segmental Vitiligo","enrollment":24},{"nctId":"NCT04418089","phase":"PHASE2","title":"Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2018-01-15","conditions":"Breast Cancer, Chemotherapy Effect","enrollment":60},{"nctId":"NCT02399709","phase":"PHASE2","title":"Trial to Evaluate the Efficacy of Simvastatin for Smoking Cessation","status":"COMPLETED","sponsor":"Poitiers University Hospital","startDate":"2015-04-01","conditions":"Smoking Cessation","enrollment":124},{"nctId":"NCT02533141","phase":"PHASE4","title":"Effect of Simvastatin Withdrawal on Ocular Endothelial Function","status":"WITHDRAWN","sponsor":"Medical University of Vienna","startDate":"2019-10","conditions":"Healthy","enrollment":""},{"nctId":"NCT00687076","phase":"PHASE4","title":"Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2004-04","conditions":"Peripheral Arterial Disease","enrollment":102},{"nctId":"NCT00842920","phase":"PHASE4","title":"Trial of Simvastatin in Amnestic Mild Cognitive Impairment (MCI) Patients","status":"UNKNOWN","sponsor":"Charite University, Berlin, Germany","startDate":"2008-12","conditions":"Mild Cognitive Impairment","enrollment":520},{"nctId":"NCT00647348","phase":"PHASE2","title":"Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2008-01","conditions":"Secondary Progressive Multiple Sclerosis","enrollment":140},{"nctId":"NCT04149080","phase":"NA","title":"Effects of Simvastatin Gel on Bone Neoformation in Post-extraction Sockets: a Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Universidade Federal Fluminense","startDate":"2017-11-01","conditions":"Alveolar Socket Preservation, Bone Regeneration","enrollment":30},{"nctId":"NCT01434745","phase":"NA","title":"SLOS: The Effect of Simvastatin in Patients Receiving Cholesterol Supplementation","status":"TERMINATED","sponsor":"Oregon Health and Science University","startDate":"2011-09","conditions":"Smith-Lemli-Opitz Syndrome","enrollment":1},{"nctId":"NCT02715726","phase":"PHASE3","title":"Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-07-27","conditions":"Hypercholesterolemia","enrollment":615},{"nctId":"NCT01890967","phase":"PHASE2","title":"A Study of LY3015014 in Participants With High Cholesterol","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2013-06","conditions":"Hypercholesterolemia","enrollment":527},{"nctId":"NCT00929955","phase":"PHASE1","title":"Role of Anti-Inflammatory Agents in Patients With Schizophrenia","status":"COMPLETED","sponsor":"Pakistan Institute of Living and Learning","startDate":"2009-06","conditions":"Schizophrenia, Schizoaffective Disorder, Psychosis Not Otherwise Specified","enrollment":36},{"nctId":"NCT01632566","phase":"PHASE1","title":"A Multiple-dose Study of LY3031207 in Healthy Participants","status":"TERMINATED","sponsor":"Eli Lilly and Company","startDate":"2012-06","conditions":"Healthy Volunteers","enrollment":39}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo of Simvastatin","genericName":"Placebo of Simvastatin","companyName":"Tanabe Pharma Corporation","companyId":"tanabe-pharma-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a placebo control formulation used in clinical trials to compare against the active simvastatin drug and has no therapeutic mechanism. Used for Control arm in Phase 3 clinical trials of simvastatin (active comparator for hyperlipidemia/cardiovascular risk reduction).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}